When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations

To determine the benefits and risks of hepatic resection versus non-resectional liver-directed treatments in patients with potentially resectable neuroendocrine liver metastases.A systematic review identified 1594 reports which alluded to a possible liver resection for neuroendocrine tumour metastases, of which 38 reports (all retrospective), comprising 3425 patients, were relevant.Thirty studies reported resection alone, and 16 studies reported...